BioLine RX Ltd ADR buy krebskrebs
Start price
30.11.20
/
50%
€1.99
Target price
30.11.21
€3.00
Performance (%)
14.57%
End price
01.12.21
€2.28
Summary
This prediction ended on 01.12.21 with a price of €2.28. The BUY prediction by krebskrebs finished with a performance of 14.57%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | -0.901% | -0.901% | -75.000% | -76.087% |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by krebskrebs for this prediction
In the thread BioLine RX Ltd ADR diskutieren
Buy mit Kursziel 3,0
In the thread Trading BioLine RX Ltd ADR
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten